Maja Sedic
Company: ReNAgade Therapeutics
Job title: Director, Toxicology
Seminars:
IND-Enabling Safety Evaluation of mRNA-LNP Cancer Therapeutic 3:00 pm
General consideration for Tox assessment of mRNA-LNP Safety evaluation of mRNA-LNP in a context of cancer immunotherapy Enabling intratumoral administrationRead more
day: Day One
Chair’s Opening Remarks 8:45 am
day: Day Two
Chair’s Closing Remarks 5:30 pm
day: Day One
Chair’s Opening Remarks 8:45 am
day: Day One